You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for NDC 72578-0133


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 72578-0133

Drug NameNDCPrice/Unit ($)UnitDate
VALSARTAN 160 MG TABLET 72578-0133-16 0.16742 EACH 2025-03-19
VALSARTAN 160 MG TABLET 72578-0133-16 0.15730 EACH 2025-02-19
VALSARTAN 160 MG TABLET 72578-0133-16 0.14772 EACH 2025-01-22
VALSARTAN 160 MG TABLET 72578-0133-16 0.15036 EACH 2024-12-18
VALSARTAN 160 MG TABLET 72578-0133-16 0.13499 EACH 2024-11-20
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 72578-0133

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Metformin Hydrochloride (NDC: 72578-0133)

Introduction

Metformin Hydrochloride, with the National Drug Code (NDC) 72578-0133, is an extended-release oral tablet used in the management of type 2 diabetes. Here, we will delve into the market analysis and price projections for this medication, considering various factors such as market trends, competition, and regulatory environments.

Market Overview

The diabetes market is one of the largest and most dynamic segments within the pharmaceutical industry. Metformin, being a first-line treatment for type 2 diabetes, holds a significant position in this market.

Prevalence of Diabetes

The global prevalence of diabetes is increasing, driven by factors such as obesity, aging populations, and sedentary lifestyles. This trend is expected to continue, thereby increasing the demand for diabetes medications like Metformin Hydrochloride[3].

Competitive Landscape

The market for metformin is highly competitive, with multiple generic versions available. Here are some key points to consider:

Generic Competition

Metformin Hydrochloride is a generic drug, and its market is characterized by intense competition from various manufacturers. The presence of multiple generic versions keeps prices relatively low and stable. For instance, the NDC 72578-036, another metformin product, is marketed by Viona Pharmaceuticals Inc, indicating a crowded market[1].

Patent Expirations and Generics

The original patents for metformin have long expired, allowing for widespread generic competition. This has led to a saturated market where prices are driven down by competition. The trend of patent expirations and the subsequent rise of generics is expected to continue, affecting the pricing strategies of pharmaceutical companies[3][4].

Pricing and Access

Pricing and access to drugs are significant concerns in the life sciences industry. Here’s how these factors impact Metformin Hydrochloride:

Pricing Trends

Given the generic nature of metformin, prices are generally stable and low. However, pricing can vary slightly depending on the manufacturer, distribution channels, and regional market conditions. For example, the prices listed in the Missouri Specialty MAC list indicate that generic drugs like metformin tend to have lower price points compared to branded or specialty drugs[2].

Access and Affordability

Access to affordable medications is a critical issue. Metformin, being a generic drug, is generally more accessible and affordable compared to branded or innovative therapies. This accessibility is crucial for managing chronic conditions like diabetes, where long-term treatment is often necessary[3].

Regulatory Environment

The regulatory environment plays a significant role in the pricing and availability of drugs.

FDA Regulations

The FDA's National Drug Code Directory provides comprehensive information on drug products, including their marketing start and end dates. For metformin products, this ensures that all marketed versions comply with FDA regulations, which can impact pricing and availability[5].

Market Listing and Delisting

The FDA's database tracks the marketing start and end dates for drug products. This information is crucial for understanding the lifecycle of a drug and how it affects pricing. For instance, if a product is delisted, it may impact the supply and pricing of remaining products in the market[5].

Market Projections

Here are some key projections for the market:

Demand Growth

The increasing prevalence of diabetes is expected to drive the demand for metformin and other diabetes medications. This growth in demand, however, will be balanced by the competitive nature of the generic market, which tends to stabilize prices[3].

Price Stability

Given the generic competition, prices for Metformin Hydrochloride are likely to remain stable. Any significant price changes would be driven by external factors such as changes in raw material costs, manufacturing efficiencies, or regulatory changes.

Impact of Innovations

While metformin itself is not an innovative therapy, advancements in diabetes management, such as personalized medicine and new therapeutic options, could indirectly affect the market. However, metformin's role as a first-line treatment ensures its continued relevance and demand[3].

Key Takeaways

  • Market Demand: The demand for metformin is expected to grow due to the increasing prevalence of diabetes.
  • Generic Competition: The market is highly competitive, with multiple generic versions available, which keeps prices stable and low.
  • Pricing Trends: Prices are generally stable and low due to generic competition.
  • Regulatory Environment: FDA regulations ensure compliance and track the lifecycle of drug products, impacting pricing and availability.
  • Innovations: Advancements in diabetes management may indirectly affect the market but are unlikely to significantly impact metformin's demand.

FAQs

  1. What is the primary use of Metformin Hydrochloride?

    • Metformin Hydrochloride is primarily used in the management of type 2 diabetes.
  2. Why are prices for Metformin Hydrochloride generally stable?

    • Prices are stable due to intense generic competition, which keeps prices low.
  3. How does the FDA regulate drug products like Metformin Hydrochloride?

    • The FDA tracks the marketing start and end dates for drug products and ensures compliance through its National Drug Code Directory.
  4. What is the impact of increasing diabetes prevalence on the demand for Metformin Hydrochloride?

    • The increasing prevalence of diabetes is expected to drive the demand for metformin and other diabetes medications.
  5. How do innovations in diabetes management affect the market for Metformin Hydrochloride?

    • Innovations in diabetes management may indirectly affect the market but are unlikely to significantly impact metformin's demand as it remains a first-line treatment.

Sources

  1. FDA.report: NDC 72578-036 - Metformin Hydrochloride.
  2. Missouri Department of Social Services: Jan-2023 MISSOURI SPECIALTY MAC NAME OF DRUG Strength.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. Drug Development: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  5. FDA: National Drug Code Directory.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.